When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa

 

Show simple item record

dc.contributor.author Schomaker, Michael en_ZA
dc.contributor.author Egger, Matthias en_ZA
dc.contributor.author Ndirangu, James en_ZA
dc.contributor.author Phiri, Sam en_ZA
dc.contributor.author Moultrie, Harry en_ZA
dc.contributor.author Technau, Karl en_ZA
dc.contributor.author Cox, Vivian en_ZA
dc.contributor.author Giddy, Janet en_ZA
dc.contributor.author Chimbetete, Cleophas en_ZA
dc.contributor.author Wood, Robin en_ZA
dc.date.accessioned 2015-11-16T04:09:41Z
dc.date.available 2015-11-16T04:09:41Z
dc.date.issued 2013 en_ZA
dc.identifier.citation Schomaker, M., Egger, M., Ndirangu, J., Phiri, S., Moultrie, H., Technau, K., ... & Davies, M. A. (2013). When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS medicine, 10(11), e1001555. doi:10.1371/journal.pmed.1001555 en_ZA
dc.identifier.uri http://hdl.handle.net/11427/15006
dc.identifier.uri http://dx.doi.org/10.1371/journal.pmed.1001555
dc.description.abstract Michael Schomaker and colleagues estimate the mortality associated with starting ART at different CD4 thresholds among children aged 2-5 years using observational data collected in cohort studies in Southern Africa. Please see later in the article for the Editors' Summary en_ZA
dc.language.iso eng en_ZA
dc.publisher Public Library of Science en_ZA
dc.rights This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. en_ZA
dc.rights.uri http://creativecommons.org/licenses/by/4.0 en_ZA
dc.source PLOS Medicince en_ZA
dc.source.uri http://journals.plos.org/plosmedicine en_ZA
dc.subject.other Children en_ZA
dc.subject.other Antiretroviral therapy en_ZA
dc.subject.other HIV en_ZA
dc.subject.other AIDS en_ZA
dc.subject.other HIV infections en_ZA
dc.subject.other Death rates en_ZA
dc.subject.other Africa en_ZA
dc.subject.other HIV epidemiology en_ZA
dc.title When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa en_ZA
dc.type Journal Article en_ZA
dc.rights.holder © 2013 Schomaker et al en_ZA
uct.type.publication Research en_ZA
uct.type.resource Article en_ZA
dc.publisher.institution University of Cape Town
dc.publisher.faculty Faculty of Health Sciences en_ZA
dc.publisher.department Institute of Infectious Disease and Molecular Medicine en_ZA
uct.type.filetype Text
uct.type.filetype Image
dc.identifier.apacitation Schomaker, M., Egger, M., Ndirangu, J., Phiri, S., Moultrie, H., Technau, K., ... Wood, R. (2013). When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. <i>PLOS Medicince</i>, http://hdl.handle.net/11427/15006 en_ZA
dc.identifier.chicagocitation Schomaker, Michael, Matthias Egger, James Ndirangu, Sam Phiri, Harry Moultrie, Karl Technau, Vivian Cox, Janet Giddy, Cleophas Chimbetete, and Robin Wood "When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa." <i>PLOS Medicince</i> (2013) http://hdl.handle.net/11427/15006 en_ZA
dc.identifier.vancouvercitation Schomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technau K, et al. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLOS Medicince. 2013; http://hdl.handle.net/11427/15006. en_ZA
dc.identifier.ris TY - Journal Article AU - Schomaker, Michael AU - Egger, Matthias AU - Ndirangu, James AU - Phiri, Sam AU - Moultrie, Harry AU - Technau, Karl AU - Cox, Vivian AU - Giddy, Janet AU - Chimbetete, Cleophas AU - Wood, Robin AB - Michael Schomaker and colleagues estimate the mortality associated with starting ART at different CD4 thresholds among children aged 2-5 years using observational data collected in cohort studies in Southern Africa. Please see later in the article for the Editors' Summary DA - 2013 DB - OpenUCT DO - 10.1371/journal.pmed.1001555 DP - University of Cape Town J1 - PLOS Medicince LK - https://open.uct.ac.za PB - University of Cape Town PY - 2013 T1 - When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa TI - When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa UR - http://hdl.handle.net/11427/15006 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.